31 October 2022
The UICC and WHO will negotiate for cheaper cancer drugs for low and low-middle-income countries via increased donations, tier pricing, or a voluntary licence mechanism.
Tag: drug price controls
7 February 2022
Pharma MNCs may deprioritise Malaysia into a “Wave 3” country, like Vietnam and South Africa, without access to innovative medicines if drug price controls are implemented.
4 February 2022
Proposed medicine price controls are estimated to result in a loss of about RM8 billion to Malaysia’s medical tourism industry by 2037, according to a cost-benefit analysis.
2 February 2022
A cost-benefit analysis estimates T20 patients with private insurance may save RM1.6 billion yearly, four times higher than RM368 million for M40 and 22 times higher than RM73 million for B40.
31 January 2022
A cost-benefit analysis finds drug price controls may shutter 2,600 clinics and cause pay cuts, salary freezes, or layoffs of 91,000 to 136,000 private health care jobs.
23 October 2020
MOH only regulates medical professional fees (consultation and procedural fees) in private health facilities, not hospital fees.
17 July 2020
MOH and KPDNHEP are preparing a price control mechanism for medicines, says Dr Adham Baba.
6 March 2020
PhRMA says medicine price ceilings may delay patient access to new treatments.
27 February 2020
Deregulation of medical practitioners’ consultation fees, jail for not issuing prescriptions upon request, drug price controls, promotion of contract government doctors, vaping regulations, mySalam, and health financing reform.
21 January 2020
The Health Ministry also pans a survey that found Malaysia has among the cheapest prices globally for some popular prescription drugs.